Skip to main content
OpenTrials
Completed

NCT Number: NCT03385447

The Effects of Faculty/Staff Exercise Program

This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Risk Factor Behavior Motor Activity Physical Activity Sedentary Behavior Sedentary Lifestyle

Age range

21 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university. Participants were regular attendees in either a 6am or 12pm exercise program session. Data included both measures of physical health as well as cognitive health. Measures of physical health included the assessment of body fat using the skin-fold method of analysis (3-site). Cholesterol was measured via blood draw analysis. This was done at the Kent State University Exercise Physiology Laboratory by certified research staff. A 6 minute walk test was completed to measure aerobic capacity. Flexibility was assessed via the sit-and-reach test while anaerobic strength and endurance were assessed using sit-up and curl-up tests. Assessment of balance was done using a Biodex Balance System.

Assessments of cognitive health included several questionnaires that asked questions related to sleep habits, stress levels, and mood. In addition, each participant was given a MOVband to track physical activity. The device was worn during waking hours for all days of participation.The data from the MOVband was auto-uploaded to a computer program for tracking so that no manual entry was necessary.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 21-65 years
  • current faculty/staff member
  • no contraindications to exercise
  • sedentary prior to enrollment

Exclusion criteria

  • age <21 years, >65 years
  • non faculty/staff member
  • contraindications to exercise
  • regular exercise participation prior to enrollment

Treatment and study plan

Physical activity

Behavioral

Participants underwent 12-weeks of exercise prescription aimed at the federal guidelines (3 days/week).

Primary outcomes

  1. Height

    Time frame: Assessed once at baseline.

    Objectively measured height in meters using a standard clinical stadiometer.

  2. Weight

    Time frame: Change from baseline weight at 4-weeks, 8-weeks, and 12-weeks follow-up.

    Objectively measured weight in kilograms using a standard clinical scale.

  3. Systolic Blood Pressure

    Time frame: Change from baseline systolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.

    Objectively measured systolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer.

  4. Diastolic Blood Pressure

    Time frame: Change from baseline diastolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.

    Objectively measured diastolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer.

  5. High-Density Lipoprotein

    Time frame: Change from baseline high-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.

    Objectively measured high-density lipoprotein in milligrams per deciliter using a standard assay kit.

  6. Low-Density Lipoprotein

    Time frame: Change from baseline low-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.

    Objectively measured low-density lipoprotein in milligrams per deciliter using a standard assay kit.

  7. Total Serum Cholesteral

    Time frame: Change from baseline total serum cholesterol at 4-weeks, 8-weeks, and 12-weeks follow-up.

    Objectively measured total serum cholesterol in milligrams per deciliter using a standard assay kit.

  8. Impaired Fasting Glucose

    Time frame: Change from baseline impaired fasting glucose at 4-weeks, 8-weeks, and 12-weeks follow-up.

    Objectively measured impaired fasting glucose in milligrams per deciliter using a standard assay kit.

Secondary outcomes

  1. Accelerometer-Based Physical Activity

    Time frame: Change from baseline accelerometer-based physical activity 4-weeks, 8-weeks, and 12-weeks follow-up using 1-minute epochs.

    Assessment of accelerometer-based physical activity outcome measures (e.g., steps per day).

Other outcomes

  1. Sleep Quality (Pittsburgh Sleep Quality Index)

    Time frame: Change from baseline sleep quality at 4-weeks, 8-weeks, and 12-weeks follow-up.

    The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval.

  2. Depression (Depression, Anxiety, and Stress Scale-21)

    Time frame: Change from baseline depression at 4-weeks, 8-weeks, and 12-weeks follow-up.

    The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.

  3. Anxiety (Depression, Anxiety, and Stress Scale-21)

    Time frame: Change from baseline anxiety at 4-weeks, 8-weeks, and 12-weeks follow-up.

    The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.

  4. Stress (Depression, Anxiety, and Stress Scale-21)

    Time frame: Change from baseline stress at 4-weeks, 8-weeks, and 12-weeks follow-up.

    The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.

  5. Mood (Profile of Mood States)

    Time frame: Change from baseline mood at 4-weeks, 8-weeks, and 12-weeks follow-up.

    The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states.

  6. Quality of Life (36-Item Short Form Survey)

    Time frame: Change from baseline quality of life at 4-weeks, 8-weeks, and 12-weeks follow-up.

    The 36-item short form survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures.

Sponsors and collaborators

Lead sponsor

Kent State University

Other

Registry information

Official study title

The Physiological and Cognitive Effects of Faculty/Staff Exercise Program in a University Setting

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Dec 28, 2017
Registry last updated
Dec 28, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.